ZD6474 (ZACTIMA™) Phase III Study in EGFR Failures

PHASE3CompletedINTERVENTIONAL
Enrollment

1,140

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

October 31, 2009

Study Completion Date

November 30, 2014

Conditions
Non-Small-Cell Lung Carcinoma
Interventions
DRUG

ZD6474 (vandetanib)

once daily oral tablet

OTHER

Best Supportive Care

standard of care

Trial Locations (102)

Unknown

Research Site, Tucson

Research Site, Germantown

Research Site, Bahía Blanca

Research Site, Ciudad de Buenos Aires

Research Site, La Plata

Research Site, Rosario

Research Site, San Miguel de Tucumán

Research Site, Santa Fe

Research Site, Fitzroy

Research Site, Perth

Research Site, St Leonards

Research Site, Tugan

Research Site, Woodville South

Research Site, Linz

Research Site, Salzburg

Research Site, Vienna

Research Site, Antwerp

Research Site, Brussels (Woluwé-St-Lambert)

Research Site, Charleroi

Research Site, Edegem

Research Site, Ghent

Research Site, Leuven

Research Site, Liège

Research Site, Edmonton

Research Site, Oshawa

Research Site, Toronto

Research Site, Montreal

Research Site, Beijing

Research Site, Chengdu

Research Site, Dalian

Research Site, Guangzhou

Research Site, Nanjing

Research Site, Shanghai

Research Site, Wuhan

Research Site, Xi'an

Research Site, Brest

Research Site, Caen

Research Site, Lyon

Research Site, Marseille

Research Site, Nice

Research Site, Pierre-Bénite

Research Site, Toulon Armees

Research Site, Bad Berka

Research Site, Donaustauf

Research Site, Frankfurt

Research Site, Gauting

Research Site, Göttingen

Research Site, Halle

Research Site, Hanover

Research Site, Karlsruhe

Research Site, Leipzig

Research Site, Löwenstein

Research Site, Mannheim

Research Site, München

Research Site, Hong Kong

Research Site, Jerusalem

Research Site, Kfar Saba

Research Site, Tel Litwinsky

Research Site, Ẕerifin

Research Site, Ancona

Research Site, Bologna

Research Site, Catania

Research Site, Genova

Research Site, Milan

Research Site, Orbassano

Research Site, Parma

Research Site, Roma

Research Site, Rozzano

Research Site, S.Andrea Delle Fratte

Research Site, Sondalo

Research Site, Udine

Research Site, México

Research Site, Zapopan

Research Site, Saint Maartenskliniek

Research Site, Lima

Research Site, Cebu City

Research Site, Manila

Research Site, Quezon City

Research Site, Singapore

Research Site, Goyang-si

Research Site, Seongnam

Research Site, Seoul

Research Site, Suwon

Research Site, Baracaldo(Vizcaya)

Research Site, Barcelona

Research Site, Santander

Research Site, Valencia

Research Site, Changhua

Research Site, Kaohsiung City

Research Site, Kaohsiung Hsien

Research Site, Liou Ying Township

Research Site, Taichung

Research Site, Taipei

Research Site, Taoyuan District

Research Site, Bangkok

Research Site, Chiang Mai

Research Site, Khon Kaen

Research Site, Birmingham

Research Site, Chelmsford

Research Site, Dundee

Research Site, Maidstone

Research Site, Manchester

All Listed Sponsors
lead

Genzyme, a Sanofi Company

INDUSTRY

NCT00404924 - ZD6474 (ZACTIMA™) Phase III Study in EGFR Failures | Biotech Hunter | Biotech Hunter